Diagnostics' Q4 2024 earnings insights, FDA resubmissions, TB & HPV test pipelines, and international market growth plans.

The US Food and Drug Administration (FDA) has granted Emergency Use Authorization (EUA) to Aptitude Medical Systems’ Metrix Covid/Flu multiplex test for over-the-counter (OTC) use. The decision ...

“The beauty of lateral flows is that they are easy to use but also easy for people to understand: you put a sample here, and a line means positive; no line is negative,” said Gonzalo Ladreda, the ...

Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the development ...

The pressure to improve outcomes may convince nursing homes to tap into new clinical resources, but not every pitch is worth ...

Looking ahead, DiaSorin anticipates continued growth into fiscal year 2025, guiding for 7% CER growth with an estimated €20 million in COVID revenues, which translates to roughly 8% growth excluding ...

As a result of the recognition of the increased impact of these viruses, new vaccines and therapeutic options have been and ...

Across all individuals, 63 had COVID-19, 95 had HIV ... “it’s an important step forward,” Arnaout said. A multiplex diagnostic test — a test that can detect multiple biomarkers from ...

A look at the exciting films and TV shows we caught at the festival, as well as which ones swung by the Den of Geek Studio at this year's SXSW!

Expanding CRISPR's Potential Since its discovery, CRISPR (“Clustered Regularly Interspaced Short Palindromic Repeats”), which ...